| Dr Amanda Jane Crosier-riffle, MD | |
|
315 S Manning Blvd, Albany, NY 12208-1707 | |
| (518) 525-1303 | |
| Not Available |
| Full Name | Dr Amanda Jane Crosier-riffle |
|---|---|
| Gender | Female |
| Speciality | Psychiatry |
| Experience | 15 Years |
| Location | 315 S Manning Blvd, Albany, New York |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1033345004 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084P0015X | Psychiatry & Neurology - Psychosomatic Medicine | 271345 (New York) | Secondary |
| 2084P0800X | Psychiatry & Neurology - Psychiatry | 271345 (New York) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Samaritan Hospital | Troy, NY | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Samaritan Hospital Of Troy, New York | 6507770070 | 180 |
News Archive
Bristol-Myers Squibb Company today announced that the U.S. Food and Drug Administration has approved a subcutaneous formulation of ORENCIA (abatacept) for the treatment of adults with moderate to severe rheumatoid arthritis.
Exiqon A/S, today announced that it has granted a non-exclusive license to BD to use Exiqon's proprietary locked nucleic acids technology in defined products for infectious disease diagnostics.
According to research presented this week at the American College of Rheumatology Annual Scientific Meeting in Chicago, participating in certain sports such as soccer, as well as elite long distance running, weight lighting and wrestling may increase the risk of developing knee osteoarthritis.
A recent survey of 376 women age 55 and over found fewer than half of them discuss osteoporosis prevention therapies with their healthcare providers, yet this bone crippling disease is one of the major reasons women eventually lose their independence and enter nursing homes.
› Verified 9 days ago
| Entity Name | Samaritan Hospital Of Troy, New York |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1043267727 PECOS PAC ID: 6507770070 Enrollment ID: O20031118000782 |
News Archive
Bristol-Myers Squibb Company today announced that the U.S. Food and Drug Administration has approved a subcutaneous formulation of ORENCIA (abatacept) for the treatment of adults with moderate to severe rheumatoid arthritis.
Exiqon A/S, today announced that it has granted a non-exclusive license to BD to use Exiqon's proprietary locked nucleic acids technology in defined products for infectious disease diagnostics.
According to research presented this week at the American College of Rheumatology Annual Scientific Meeting in Chicago, participating in certain sports such as soccer, as well as elite long distance running, weight lighting and wrestling may increase the risk of developing knee osteoarthritis.
A recent survey of 376 women age 55 and over found fewer than half of them discuss osteoporosis prevention therapies with their healthcare providers, yet this bone crippling disease is one of the major reasons women eventually lose their independence and enter nursing homes.
› Verified 9 days ago
| Entity Name | Albany Medical College |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1629008537 PECOS PAC ID: 1759293111 Enrollment ID: O20031125000386 |
News Archive
Bristol-Myers Squibb Company today announced that the U.S. Food and Drug Administration has approved a subcutaneous formulation of ORENCIA (abatacept) for the treatment of adults with moderate to severe rheumatoid arthritis.
Exiqon A/S, today announced that it has granted a non-exclusive license to BD to use Exiqon's proprietary locked nucleic acids technology in defined products for infectious disease diagnostics.
According to research presented this week at the American College of Rheumatology Annual Scientific Meeting in Chicago, participating in certain sports such as soccer, as well as elite long distance running, weight lighting and wrestling may increase the risk of developing knee osteoarthritis.
A recent survey of 376 women age 55 and over found fewer than half of them discuss osteoporosis prevention therapies with their healthcare providers, yet this bone crippling disease is one of the major reasons women eventually lose their independence and enter nursing homes.
› Verified 9 days ago
| Entity Name | St Peters Hospital Of The City Of Albany |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1518042357 PECOS PAC ID: 2668460072 Enrollment ID: O20040504001301 |
News Archive
Bristol-Myers Squibb Company today announced that the U.S. Food and Drug Administration has approved a subcutaneous formulation of ORENCIA (abatacept) for the treatment of adults with moderate to severe rheumatoid arthritis.
Exiqon A/S, today announced that it has granted a non-exclusive license to BD to use Exiqon's proprietary locked nucleic acids technology in defined products for infectious disease diagnostics.
According to research presented this week at the American College of Rheumatology Annual Scientific Meeting in Chicago, participating in certain sports such as soccer, as well as elite long distance running, weight lighting and wrestling may increase the risk of developing knee osteoarthritis.
A recent survey of 376 women age 55 and over found fewer than half of them discuss osteoporosis prevention therapies with their healthcare providers, yet this bone crippling disease is one of the major reasons women eventually lose their independence and enter nursing homes.
› Verified 9 days ago
| Entity Name | Albany Medical College |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1447284328 PECOS PAC ID: 1759293111 Enrollment ID: O20040517000953 |
News Archive
Bristol-Myers Squibb Company today announced that the U.S. Food and Drug Administration has approved a subcutaneous formulation of ORENCIA (abatacept) for the treatment of adults with moderate to severe rheumatoid arthritis.
Exiqon A/S, today announced that it has granted a non-exclusive license to BD to use Exiqon's proprietary locked nucleic acids technology in defined products for infectious disease diagnostics.
According to research presented this week at the American College of Rheumatology Annual Scientific Meeting in Chicago, participating in certain sports such as soccer, as well as elite long distance running, weight lighting and wrestling may increase the risk of developing knee osteoarthritis.
A recent survey of 376 women age 55 and over found fewer than half of them discuss osteoporosis prevention therapies with their healthcare providers, yet this bone crippling disease is one of the major reasons women eventually lose their independence and enter nursing homes.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Amanda Jane Crosier-riffle, MD Po Box 14890, Albany, NY 12212-4890 Ph: (518) 525-5634 | Dr Amanda Jane Crosier-riffle, MD 315 S Manning Blvd, Albany, NY 12208-1707 Ph: (518) 525-1303 |
News Archive
Bristol-Myers Squibb Company today announced that the U.S. Food and Drug Administration has approved a subcutaneous formulation of ORENCIA (abatacept) for the treatment of adults with moderate to severe rheumatoid arthritis.
Exiqon A/S, today announced that it has granted a non-exclusive license to BD to use Exiqon's proprietary locked nucleic acids technology in defined products for infectious disease diagnostics.
According to research presented this week at the American College of Rheumatology Annual Scientific Meeting in Chicago, participating in certain sports such as soccer, as well as elite long distance running, weight lighting and wrestling may increase the risk of developing knee osteoarthritis.
A recent survey of 376 women age 55 and over found fewer than half of them discuss osteoporosis prevention therapies with their healthcare providers, yet this bone crippling disease is one of the major reasons women eventually lose their independence and enter nursing homes.
› Verified 9 days ago
Dr. Stanley F Penc, MD PHD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 400 Patroon Creek Blvd, Suite 210, Albany, NY 12206 Phone: 518-459-8106 | |
Dr. Donald Stone Higgins Jr., M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 113 Holland Ave, Neurology Service (127), Albany, NY 12208 Phone: 518-626-6391 Fax: 518-626-6369 | |
Dr. Christopher John Hanowitz, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 47 New Scotland Ave, Department Of Emergency Medicine, Albany, NY 12208 Phone: 518-262-3095 | |
Daniel Gabriels, Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 75 New Scotland Ave, Albany, NY 12208 Phone: 518-447-9611 | |
Ryan Patrick Bochacki, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 113 Holland Ave, Albany, NY 12208 Phone: 518-626-5991 | |
Robert F. Malerba Ii, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 732 Madison Ave, Albany, NY 12208 Phone: 518-436-0874 |